Communicating the benefits and harms of anticancer drugs. | BMJ;380: 623, 2023 03 29. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Communicating the benefits and harms of anticancer drugs.

Feeney, Timothy; Villanueva, Tiago; Price, Amy.

Feeney T; The BMJ, London, UK tfeeney@bmj.com.
Villanueva T; The BMJ, London, UK.
Price A; The BMJ, London, UK.

BMJ ; 380: 623, 2023 03 29.

Article in English | MEDLINE | ID: covidwho-2258899

Subject(s)

Antineoplastic Agents; Communication; Humans; Risk Assessment; Antineoplastic Agents/adverse effects

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communication / Antineoplastic Agents Type of study: Prognostic study Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2023 Document Type: Article Affiliation country: Bmj.p623

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communication / Antineoplastic Agents Type of study: Prognostic study Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2023 Document Type: Article Affiliation country: Bmj.p623